Navigation Links
LSU biologist, chemical engineer partner with industry to develop best soft lure available
Date:2/7/2011

n," said Caprio. "Attraxx is the most effective lure out there because it has many years of scientific research behind it. Sci-X is evenly dispersed throughout each lure so that even if a piece breaks off, the rest can still catch fish."

Knowing the appropriate chemicals to use is the first step in developing a scientifically-designed fishing lure, but creating the appropriate matrix to hold those chemicals and release them into the water in an efficient, beneficial way is equally important.

"LSU's Office of Intellectual Property was integral in the development of Attraxx," said Caprio. "After going through the office to license the Sci-X compound I created to Mystic Tackleworks, they connected me with a member of the chemical engineering faculty here, Professor James Henry, an expert in composite materials."

Henry, whose primary work involves developing matrixes to replace bone destroyed in catastrophic accident or disease, was excited by the somewhat out-of-the-ordinary offer of collaboration.

"This was a really interesting project to work on," said Henry. "I never imagined that I would be working on soft fishing lures in my life, but I couldn't be happier with the project."

The turnaround involved was a bonus for Henry, too.

"Working with materials that impact human health is very fulfilling but very time consuming," said Henry. "I won't see completion of most of my projects in my lifetime, but I received packages of Attraxx just last month. It's really a nice feeling to see the final outcome of your work and know it's been successful."

While expertise in developing biomaterials was essential to forming a successful matrix for the lure, so was knowledge about the actual sport of fishing.

"There are a lot of soft baits on the market. Most of them are just plastic there's no chemical scent, just visual and mechanical stimuli," said Caprio. "Those that do have some chemical basis are messy, inconveni
'/>"/>

Contact: Ashley Berthelot
aberth4@lsu.edu
225-578-3870
Louisiana State University
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Chemical equator discovery will aid pollution mapping
2. Researcher working on destruction of chemical weapons
3. Argonne scientists peer into heart of compound that may detect chemical, biological weapons
4. American Chemical Societys Weekly PressPac -- Sept. 24, 2008
5. A major prize in the chemical sciences announced by the Camille and Henry Dreyfus Foundation
6. American Chemical Societys Weekly PressPac
7. American Chemical Society Weekly PressPac Oct. 15, 2008
8. UC Davis chemical ecologist wins major award
9. Sniffing out a better chemical sensor
10. Simple chemical procedure augments therapeutic potential of stem cells
11. Researchers use chemical from medicinal plants to fight HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 26, 2015 Research and ... of the "Saudi Arabia Biometric Systems Market ... offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The biometric systems ... is projected to grow at over 22% CAGR ... attributed to the surging demand for better biometric ...
(Date:5/25/2015)... SYDNEY , May 25, 2015  Australia,s market ... inception stage, although 2014 saw the advent of several ... on 24 April 2015 is expected to ignite interest ... devices in Australia . This in ... the industry and drive new partnerships amongst vendors and ...
(Date:5/22/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... ending its promotional pricing and making the Wocket generally available ... Savin , Head of Marketing said, "We,ve extended the opportunity ... end of May. To get your wocket at this special ... the store on June 1, you,ll receive a unique code ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3
... many aspects of who we are from the colour ... but how are the genes, and consequently the proteins they ... new group of molecules which control some of the fundamental ... developing new therapies for treating neurodegenerative diseases. The research, ...
... paper published today in Nature,s open access journal Scientific ... that male pseudoscorpions treated with the antibiotic tetracycline suffer significantly ... their untreated sons. They suggest that a similar effect could ... first research to show a transgenerational effect of antibiotics," David ...
... April 27, 2012 Aware, Inc. (NASDAQ: AWRE ), ... today reported financial results for its first quarter ended March 31, ... were $5.7 million, a decrease of 10% compared to $6.4 million ... quarter of 2012 was $1.1 million, or $0.05 per diluted share. ...
Cached Biology News:Doubling the information from the double helix 2University of Nevada, Reno first to show transgenerational effect of antibiotics 2Aware, Inc. Reports First Quarter 2012 Financial Results 2Aware, Inc. Reports First Quarter 2012 Financial Results 3Aware, Inc. Reports First Quarter 2012 Financial Results 4Aware, Inc. Reports First Quarter 2012 Financial Results 5
(Date:5/26/2015)... REDWOOD CITY , Kalifornien und HILDEN, ... QIAGEN Clinical Insight ... Interpretation von Genvarianten und die Erstellung dazugehöriger ... und ESHG     QIAGEN N.V. ... QIA) gab heute die Markteinführung von QIAGEN ...
(Date:5/26/2015)... China , May 26, 2015 Tianyin ... company that specializes in the patented biopharmaceutical, modernized traditional ... (API), announced that the Company,s Annual Meeting of Shareholders ... scheduled to be held at the Company,s office located ... conference call, at 9:00 AM (local time in ...
(Date:5/26/2015)... , May 26, 2015 Pharmaco-Kinesis Corporation (PKC) ... recently convened at Shutters on the Beach in ... development status of the Company,s innovative Metronomic Biofeedback Pump ... locally deliver chemotherapy over time to a target site ... capacity and biofeedback system in real-time.  ...
(Date:5/26/2015)... 2015 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery ... protocol for the company,s Phase IIb trial of ORMD-0801, ... Drug Administration (FDA). The submission was made under the ... The Phase IIb study of ORMD-0801 for type 2 ...
Breaking Biology Technology:QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 2QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 3QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 4QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 5QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 6TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 2TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 3Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 2Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 3Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 4Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 5Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 3
... American Society of Clinical Oncology (ASCO) Meeting Show Fleximer(R) ... Prolonged Stable Disease in Refractory Tumors - , ... preliminary results of a Phase 1 clinical trial for ... at the 2009 Annual Meeting of the American Society ...
... , - Webinar on June 9 to discuss the prevalence ... at www.connecttoprotect.com - , ... Gastroenterological Association (AGA) Institute and Horizon Therapeutics, Inc. today launched ... about the gastrointestinal (GI) risks associated with the use of ...
... CHICAGO, June 1 UCB, Inc. and the ... of the 2009 Research Awards in Inflammatory Bowel Disease (IBD) ... research grant for their original clinical or basic research, totaling ... the CDWG Steering Committee and the awards were funded by ...
Cached Biology Technology:Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors 2Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors 3AGA Institute and Horizon Therapeutics Launch 'Connect to Protect' Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 2AGA Institute and Horizon Therapeutics Launch 'Connect to Protect' Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 3UCB and Crohn's Disease Working Group Award $175,000 in Research Grants to Gastroenterology Fellows 2
Porcine TNF-alpha/TNFSF1A ELISpot Development Module...
Request Info...
Services include subcloning into an expression vector. Tagged protein will be expressed in small scale for testing yield and solubility and then in 1L culture for large scale affinity purification. E...
...
Biology Products: